S
Silence Therapeutics
London, United Kingdom
Founded 1994 NASDAQ: SLN
About
Pioneer in precision RNAi medicines using mRNAi GOLD platform with GalNAc delivery
Company Details
- Type
- commercial
- Employees
- 100-200
- Funding
- Public
Key Products
- Zerlasiran
- mRNAi GOLD Platform